Francisco Cruzalegui

3.8k total citations
51 papers, 2.9k citations indexed

About

Francisco Cruzalegui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Francisco Cruzalegui has authored 51 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Francisco Cruzalegui's work include Protein Kinase Regulation and GTPase Signaling (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Cancer-related Molecular Pathways (5 papers). Francisco Cruzalegui is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Cancer-related Molecular Pathways (5 papers). Francisco Cruzalegui collaborates with scholars based in France, United Kingdom and United States. Francisco Cruzalegui's co-authors include Anthony R. Means, Richard Treisman, Hilmar Bading, Giles E. Hardingham, Sangeeta Chawla, Thierry Lorca, Jean‐Claude Cavadore, Marcel Dorée, Didier Fesquet and Jean Méry and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Francisco Cruzalegui

49 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Cruzalegui France 25 2.0k 472 415 399 335 51 2.9k
C. James Hastie United Kingdom 26 3.0k 1.5× 649 1.4× 440 1.1× 650 1.6× 332 1.0× 37 4.2k
Hilary McLauchlan United Kingdom 13 3.2k 1.6× 775 1.6× 537 1.3× 821 2.1× 298 0.9× 16 4.6k
Elizabeth J. Manos United States 12 2.3k 1.1× 563 1.2× 378 0.9× 337 0.8× 421 1.3× 13 3.5k
Theodora S. Ross United States 32 2.0k 1.0× 506 1.1× 363 0.9× 777 1.9× 299 0.9× 63 3.6k
Steve Arkinstall United States 25 3.4k 1.7× 496 1.1× 501 1.2× 582 1.5× 331 1.0× 34 4.3k
Néstor Gómez Spain 24 2.7k 1.4× 436 0.9× 449 1.1× 593 1.5× 250 0.7× 46 3.4k
Marek Liyanage United States 18 2.6k 1.3× 862 1.8× 168 0.4× 463 1.2× 560 1.7× 22 3.2k
Serge Roche France 37 3.1k 1.6× 1.0k 2.2× 348 0.8× 839 2.1× 371 1.1× 92 4.5k
Julie Nardone United States 16 2.9k 1.5× 644 1.4× 286 0.7× 254 0.6× 503 1.5× 18 4.0k
James Posada United States 19 1.8k 0.9× 383 0.8× 176 0.4× 468 1.2× 155 0.5× 27 2.5k

Countries citing papers authored by Francisco Cruzalegui

Since Specialization
Citations

This map shows the geographic impact of Francisco Cruzalegui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Cruzalegui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Cruzalegui more than expected).

Fields of papers citing papers by Francisco Cruzalegui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Cruzalegui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Cruzalegui. The network helps show where Francisco Cruzalegui may publish in the future.

Co-authorship network of co-authors of Francisco Cruzalegui

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Cruzalegui. A scholar is included among the top collaborators of Francisco Cruzalegui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Cruzalegui. Francisco Cruzalegui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, James T., Urszula M. Polanska, Oona Delpuech, et al.. (2018). Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors. Molecular Cancer Therapeutics. 17(11). 2309–2319. 18 indexed citations
2.
Maubant, Sylvie, Tania Tahtouh, Virginie Maire, et al.. (2018). LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers. Oncotarget. 9(32). 22586–22604. 20 indexed citations
3.
Lynch, James T., Urszula M. Polanska, Oona Delpuech, et al.. (2017). Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors. Clinical Cancer Research. 23(24). 7584–7595. 24 indexed citations
4.
Hudson, Kevin, Urs J. Hancox, Cath Trigwell, et al.. (2016). Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA -Dependent Breast Cancers. Molecular Cancer Therapeutics. 15(5). 877–889. 36 indexed citations
5.
Maubant, Sylvie, Bruno Tesson, Virginie Maire, et al.. (2015). Abstract 41: The Wnt3a targetome in triple-negative breast cancer cell lines. Cancer Research. 75(15_Supplement). 41–41. 2 indexed citations
6.
Maubant, Sylvie, Bruno Tesson, Virginie Maire, et al.. (2015). Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells. PLoS ONE. 10(4). e0122333–e0122333. 61 indexed citations
7.
Maubant, Sylvie, Virginie Maire, Bruno Tesson, et al.. (2014). Abstract 2764: The depletion of LRP5, unlike that of LRP6, promotes apoptosis in triple-negative breast cancer cells, making it an interesting therapeutic target. Cancer Research. 74(19_Supplement). 2764–2764. 1 indexed citations
8.
Burbridge, Mike F., Céline Bossard, Imre Fejes, et al.. (2013). S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab. Molecular Cancer Therapeutics. 12(9). 1749–1762. 74 indexed citations
9.
Maire, Virginie, Céline Baldeyron, Marion Richardson, et al.. (2013). TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer. PLoS ONE. 8(5). e63712–e63712. 119 indexed citations
10.
Dumont, Aurélie, Audrey Sirvent, Michel Jan, et al.. (2011). Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells. PLoS ONE. 6(2). e17237–e17237. 33 indexed citations
11.
Maire, Virginie, Eléonore Gravier, Guillem Rigaill, et al.. (2008). Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Research. 10(6). R101–R101. 170 indexed citations
12.
Golsteyn, Roy M., et al.. (2006). Synthesis, in vitro antiproliferative activities, and Chk1 inhibitory properties of indolylpyrazolones and indolylpyridazinedione. European Journal of Medicinal Chemistry. 41(12). 1470–1477. 14 indexed citations
13.
Wallez, Yann, Francine Cand, Francisco Cruzalegui, et al.. (2006). Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene. 26(7). 1067–1077. 177 indexed citations
14.
Cruzalegui, Francisco & Hilmar Bading. (2000). Calcium-regulated protein kinase cascades and their transcription factor targets. Cellular and Molecular Life Sciences. 57(3). 402–410. 64 indexed citations
15.
Cruzalegui, Francisco. (1999). c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation. The EMBO Journal. 18(5). 1335–1344. 64 indexed citations
16.
Hardingham, Giles E., Sangeeta Chawla, Francisco Cruzalegui, & Hilmar Bading. (1999). Control of Recruitment and Transcription-Activating Function of CBP Determines Gene Regulation by NMDA Receptors and L-Type Calcium Channels. Neuron. 22(4). 789–798. 240 indexed citations
17.
Cruzalegui, Francisco, Eva Cano, & Richard Treisman. (1999). ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene. 18(56). 7948–7957. 149 indexed citations
18.
Means, Anthony R. & Francisco Cruzalegui. (1993). Differential Gene Expression from a Single Transcription Unit during Spermatogenesis. PubMed. 48. 79–97. 7 indexed citations
19.
Lorca, Thierry, Francisco Cruzalegui, Didier Fesquet, et al.. (1993). Calmodulin-dependent protein kinase II mediates inactivation of MPF and CSF upon fertilization of Xenopus eggs. Nature. 366(6452). 270–273. 384 indexed citations
20.
Hanley, Rochelle M., et al.. (1989). Sequence of the cDNA for the alpha subunit of calmodulin kinase II from mouse brain. Nucleic Acids Research. 17(10). 3992–3992. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. James Hastie Breakdown of academic impact, for papers by Hilary McLauchlan Breakdown of academic impact, for papers by Elizabeth J. Manos Breakdown of academic impact, for papers by Theodora S. Ross Breakdown of academic impact, for papers by Steve Arkinstall Breakdown of academic impact, for papers by Néstor Gómez Breakdown of academic impact, for papers by Marek Liyanage Breakdown of academic impact, for papers by Serge Roche Breakdown of academic impact, for papers by Julie Nardone Breakdown of academic impact, for papers by James Posada
Rankless by CCL
2026